SCILEX HOLDING COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.13 USD | +3.67% |
|
+25.56% | -44.61% |
| May. 24 | Sector Update: Health Care Stocks Decline Late Friday Afternoon | MT |
| May. 24 | Sector Update: Health Care | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 564 | 199.6 | 136.9 | - | - |
| Enterprise Value (EV) 1 | 564 | 199.6 | 136.9 | 136.9 | 136.9 |
| P/E ratio | -23.5 x | -1.59 x | -2.4 x | -4.13 x | -5.65 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 4.27 x | 1.89 x | 1.14 x | 1.13 x |
| EV / Revenue | - | 4.27 x | 1.89 x | 1.14 x | 1.13 x |
| EV / EBITDA | - | - | - | - | - |
| EV / FCF | - | - | -1.25 x | -1.52 x | -3.4 x |
| FCF Yield | - | - | -80.2% | -65.8% | -29.4% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 141,349 | 97,837 | 121,121 | - | - |
| Reference price 2 | 3.990 | 2.040 | 1.130 | 1.130 | 1.130 |
| Announcement Date | 3/7/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 46.74 | 72.38 | 120.2 | 121.3 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | - | -105.4 | -79.81 | -64.92 | -53 |
| Operating Margin | - | -225.55% | -110.26% | -54% | -43.69% |
| Earnings before Tax (EBT) 1 | - | -114.3 | -87.48 | -59.55 | -53 |
| Net income 1 | -23.36 | -114.3 | -87.48 | -59.55 | -58.3 |
| Net margin | - | -244.59% | -120.85% | -49.53% | -48.06% |
| EPS 2 | -0.1700 | -1.280 | -0.4700 | -0.2733 | -0.2000 |
| Free Cash Flow 1 | - | - | -109.7 | -90 | -40.3 |
| FCF margin | - | - | -151.55% | -74.86% | -33.22% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/7/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 10.12 | 13.46 | 10.88 | 15.21 | 20.85 | 25.44 | 28.75 | 33.35 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | -38.8 | -18.34 | -19.48 | -23.66 | -19.82 | -16.84 | - | - |
| Operating Margin | - | -383.56% | -136.23% | -178.96% | -155.62% | -95.08% | -66.19% | - | - |
| Earnings before Tax (EBT) 1 | - | -35.53 | -21.39 | -24.38 | -25.05 | -20.77 | -17.27 | - | - |
| Net income 1 | -26.65 | -35.53 | -21.39 | -24.38 | -25.05 | -20.77 | -17.27 | - | - |
| Net margin | - | -351.18% | -158.87% | -223.97% | -164.76% | -99.64% | -67.88% | - | - |
| EPS 2 | -0.1900 | -0.6300 | -0.2500 | -0.2400 | -0.1400 | -0.1000 | -0.0700 | -0.0850 | -0.0550 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/11/23 | 11/14/23 | 3/12/24 | 5/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | - | -110 | -90 | -40.3 |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 3/7/23 | 3/12/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.13
USD
Average target price
5.167
USD
Spread / Average Target
+357.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -44.61% | 137M | |
| +8.35% | 8.72B | |
| -16.83% | 4.79B | |
| +47.36% | 4.62B | |
| +1.74% | 3.82B | |
| +14.51% | 2.33B | |
| -26.23% | 2.2B | |
| +15.63% | 2.1B | |
| -34.87% | 2.04B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- SCLX Stock
- Financials Scilex Holding Company
